The Antiarrhythmic Activity of N-alkyl-1,2-diphenylethanolamines
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The activity of N-alkyl-1,2-diphenylethanolamines against CaCl2-induced cardiac arrhythmia was evaluated in the rat. The potencies of the compounds were compared with that of the established calcium ion-channel blocker, verapamil. The N-methyl, N-ethyl, and N-isobutyl derivatives as well as verapamil at doses of 2-8 mumols kg-1 protected the animals against the induced arrhythmia. The potency order was verapamil greater than N methyl greater than N-ethyl greater than N-isobutyl derivatives. The N-isopropyl and N-butyl derivatives were inactive. The antiarrhythmic activity of the compounds was not due to local anesthetic activity but may be caused by calcium-channel inhibition.
References
1.
Zipes D, Fischer J
. Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog. Circ Res. 1974; 34(2):184-92.
DOI: 10.1161/01.res.34.2.184.
View
2.
El-Obeid H, Madani A, Al-Rashood K, El Tahir K, Tilmisani A, Ibrahim M
. Synthesis and pharmacological activity of N-alkyl-1,2-diphenylethanolamines. Pharm Res. 1987; 4(2):166-70.
DOI: 10.1023/a:1016435523349.
View
3.
Yamada K, Shimamura T, Nakajima H
. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions. Jpn J Pharmacol. 1973; 23(3):321-8.
DOI: 10.1254/jjp.23.321.
View
4.
Antman E, Stone P, Muller J, Braunwald E
. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. Ann Intern Med. 1980; 93(6):875-85.
DOI: 10.7326/0003-4819-93-6-875.
View
5.
FLECKENSTEIN A
. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977; 17:149-66.
DOI: 10.1146/annurev.pa.17.040177.001053.
View